100 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

1681

Consun Pharmaceutical Group
HK$5.78-1.0%20.4%HK$4.6bHK$7.10PE5.8xE13.4%5.1%

1061

Essex Bio-Technology
HK$2.360%-39.3%HK$1.3bHK$5.12PE4.9xE28.7%3.8%

867

China Medical System Holdings
HK$12.541.5%-1.4%HK$30.7bHK$17.85PE8.4xE8.6%4.8%

2005

SSY Group
HK$4.56-2.4%7.3%HK$13.5bHK$5.99PE11.4xE20.4%3.3%

3933

United Laboratories International Holdings
HK$9.24-3.2%63.3%HK$16.8bHK$11.39PE6.9xE3.5%3.7%

2877

China Shineway Pharmaceutical Group
HK$9.93-3.4%34.2%HK$7.5bHK$9.23PE7.8xE10.4%4.7%

2096

Simcere Pharmaceutical Group
HK$5.371.3%-35.0%HK$14.0bHK$8.82PE4.1xE-29.6%3.2%

239

Pak Fah Yeow International
HK$2.05-0.5%68.0%HK$638.9mn/aPE6.1xn/a6.0%

2161

JBM (Healthcare)
HK$0.86-4.4%-14.9%HK$712.4mn/aPE7.3xn/a8.0%

6600

SciClone Pharmaceuticals (Holdings)
HK$16.040%52.8%HK$9.8bHK$15.80PE9.5xE8.2%2.3%

1666

Tong Ren Tang Technologies
HK$4.96-4.6%-28.7%HK$6.4bHK$7.44PE9.9xE7.1%3.9%

6826

Shanghai Haohai Biological Technology
HK$39.50-6.6%-0.5%HK$16.4bHK$70.01PE14.7xE22.4%2.7%

3613

Beijing Tong Ren Tang Chinese Medicine
HK$8.94-5.5%-34.6%HK$7.5bHK$13.93PE13.8xE15.2%3.7%

719

Shandong Xinhua Pharmaceutical
HK$5.29-4.7%-14.4%HK$9.8bn/aPE6.5xn/a4.1%

1530

3SBio
HK$5.744.4%-30.0%HK$13.8bHK$7.51PE6.6xE4.4%1.6%

8049

Jilin Province Huinan Changlong Bio-pharmacy
HK$1.75-5.4%52.2%HK$980.4mn/aPE4.1xn/a30.9%

3737

Zhongzhi Pharmaceutical Holdings
HK$1.21-13.6%18.6%HK$1.0bn/aPE5.9xn/a4.9%

3320

China Resources Pharmaceutical Group
HK$5.090.4%-29.7%HK$32.0bHK$7.25PE7.7xE10.7%3.3%

512

Grand Pharmaceutical Group
HK$4.219.4%-8.5%HK$14.7bn/aPE7.8xE20.0%6.2%

2633

Jacobson Pharma
HK$0.58-3.3%-37.6%HK$1.2bn/aPE4.7xn/a8.4%

9926

Akeso
HK$46.65-8.0%13.4%HK$39.2bHK$59.81PE17.9xE12.4%n/a

1521

Frontage Holdings
HK$1.41-10.2%-40.8%HK$2.9bHK$1.93PE21xE25.0%n/a

2268

WuXi XDC Cayman
HK$17.043.0%n/aHK$20.1bHK$32.90PE65.4xE34.0%n/a

1889

Sanai Health Industry Group
HK$0.04-18.4%-51.8%HK$128.4mn/aPE3.2xn/a0%
Page 1 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.